Overview
SCIENTIFIC SCORE
Likely Very Effective
Based on 1 Research
9
USERS' SCORE
Moderately Good
Based on 3 Reviews
7.1
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
Zinc (as Zinc bisglycinate)
30 mg
273%
Top Medical Research Studies
9
We explored the effectiveness of a modified bismuth quadruple therapy that includes zinc carnosine, in comparison to the traditional triple therapy for treating indigestion caused by Helicobacter pylori infection. In our study, 92 patients with symptoms of dyspepsia and positive breath tests were randomly assigned to receive either the conventional treatment of esomeprazole, amoxicillin, and clarithromycin for 14 days, or a shorter 10-day course of the new therapy that also included bismuth subcitrate and zinc carnosine.
The results were quite revealing. Our findings showed that the modified bismuth quadruple therapy group had a significantly higher eradication rate of 93.5%, compared to 69.6% in the standard treatment group. This suggests that the addition of zinc carnosine to the treatment regimen could enhance the effectiveness of indigestion relief. Importantly, the side effects reported between the two groups were similar, with only mild dizziness noted in those receiving the new therapy.
Overall, the study indicates that a shorter course of therapy that includes zinc carnosine may be a superior option for individuals suffering from indigestion related to Helicobacter pylori. This approach not only appears to work better but also does not lead to more serious side effects, making it an appealing alternative to traditional treatment methods.
The results were quite revealing. Our findings showed that the modified bismuth quadruple therapy group had a significantly higher eradication rate of 93.5%, compared to 69.6% in the standard treatment group. This suggests that the addition of zinc carnosine to the treatment regimen could enhance the effectiveness of indigestion relief. Importantly, the side effects reported between the two groups were similar, with only mild dizziness noted in those receiving the new therapy.
Overall, the study indicates that a shorter course of therapy that includes zinc carnosine may be a superior option for individuals suffering from indigestion related to Helicobacter pylori. This approach not only appears to work better but also does not lead to more serious side effects, making it an appealing alternative to traditional treatment methods.
Most Useful Reviews
0
Severe indigestion experienced
2 people found this helpful
Unfortunately, this zinc did not work for me; it caused severe abdominal pain and indigestion. I had to stop taking it.
6
Improved condition noted
4 people found this helpful
A good helper in improving skin and hair, I am satisfied with this zinc option. After a disappointing experience with zinc sulfate (indigestion, nausea), I was pleased to find that I had no discomfort with this chelate form, provided I took it after meals. On two occasions I neglected to eat first and felt a bit nauseous, but I quickly adjusted. My goal is to enhance my skin and hair condition, and while it’s too early to assess the success, it certainly hasn’t worsened.
0
Guaranteed indigestion warning
1 people found this helpful
It helps at the first sign of a cold and truly works. I take one tablet three times a day, but only after meals; otherwise, indigestion is guaranteed. I also experience frequent stomach aches.
Medical Researches
SCIENTIFIC SCORE
Likely Very Effective
Based on 1 Research
9
- All Researches
9
We explored the effectiveness of a modified bismuth quadruple therapy that includes zinc carnosine, in comparison to the traditional triple therapy for treating indigestion caused by Helicobacter pylori infection. In our study, 92 patients with symptoms of dyspepsia and positive breath tests were randomly assigned to receive either the conventional treatment of esomeprazole, amoxicillin, and clarithromycin for 14 days, or a shorter 10-day course of the new therapy that also included bismuth subcitrate and zinc carnosine.
The results were quite revealing. Our findings showed that the modified bismuth quadruple therapy group had a significantly higher eradication rate of 93.5%, compared to 69.6% in the standard treatment group. This suggests that the addition of zinc carnosine to the treatment regimen could enhance the effectiveness of indigestion relief. Importantly, the side effects reported between the two groups were similar, with only mild dizziness noted in those receiving the new therapy.
Overall, the study indicates that a shorter course of therapy that includes zinc carnosine may be a superior option for individuals suffering from indigestion related to Helicobacter pylori. This approach not only appears to work better but also does not lead to more serious side effects, making it an appealing alternative to traditional treatment methods.
The results were quite revealing. Our findings showed that the modified bismuth quadruple therapy group had a significantly higher eradication rate of 93.5%, compared to 69.6% in the standard treatment group. This suggests that the addition of zinc carnosine to the treatment regimen could enhance the effectiveness of indigestion relief. Importantly, the side effects reported between the two groups were similar, with only mild dizziness noted in those receiving the new therapy.
Overall, the study indicates that a shorter course of therapy that includes zinc carnosine may be a superior option for individuals suffering from indigestion related to Helicobacter pylori. This approach not only appears to work better but also does not lead to more serious side effects, making it an appealing alternative to traditional treatment methods.
User Reviews
USERS' SCORE
Moderately Good
Based on 3 Reviews
7.1
- All Reviews
- Positive Reviews
- Negative Reviews
0
Severe indigestion experienced
2 people found this helpful
Unfortunately, this zinc did not work for me; it caused severe abdominal pain and indigestion. I had to stop taking it.
6
Improved condition noted
4 people found this helpful
A good helper in improving skin and hair, I am satisfied with this zinc option. After a disappointing experience with zinc sulfate (indigestion, nausea), I was pleased to find that I had no discomfort with this chelate form, provided I took it after meals. On two occasions I neglected to eat first and felt a bit nauseous, but I quickly adjusted. My goal is to enhance my skin and hair condition, and while it’s too early to assess the success, it certainly hasn’t worsened.
0
Guaranteed indigestion warning
1 people found this helpful
It helps at the first sign of a cold and truly works. I take one tablet three times a day, but only after meals; otherwise, indigestion is guaranteed. I also experience frequent stomach aches.
Frequently Asked Questions
6
Improved condition noted
4 people found this helpful
A good helper in improving skin and hair, I am satisfied with this zinc option. After a disappointing experience with zinc sulfate (indigestion, nausea), I was pleased to find that I had no discomfort with this chelate form, provided I took it after meals. On two occasions I neglected to eat first and felt a bit nauseous, but I quickly adjusted. My goal is to enhance my skin and hair condition, and while it’s too early to assess the success, it certainly hasn’t worsened.
0
Severe indigestion experienced
2 people found this helpful
Unfortunately, this zinc did not work for me; it caused severe abdominal pain and indigestion. I had to stop taking it.
0
Guaranteed indigestion warning
1 people found this helpful
It helps at the first sign of a cold and truly works. I take one tablet three times a day, but only after meals; otherwise, indigestion is guaranteed. I also experience frequent stomach aches.
9
We explored the effectiveness of a modified bismuth quadruple therapy that includes zinc carnosine, in comparison to the traditional triple therapy for treating indigestion caused by Helicobacter pylori infection. In our study, 92 patients with symptoms of dyspepsia and positive breath tests were randomly assigned to receive either the conventional treatment of esomeprazole, amoxicillin, and clarithromycin for 14 days, or a shorter 10-day course of the new therapy that also included bismuth subcitrate and zinc carnosine.
The results were quite revealing. Our findings showed that the modified bismuth quadruple therapy group had a significantly higher eradication rate of 93.5%, compared to 69.6% in the standard treatment group. This suggests that the addition of zinc carnosine to the treatment regimen could enhance the effectiveness of indigestion relief. Importantly, the side effects reported between the two groups were similar, with only mild dizziness noted in those receiving the new therapy.
Overall, the study indicates that a shorter course of therapy that includes zinc carnosine may be a superior option for individuals suffering from indigestion related to Helicobacter pylori. This approach not only appears to work better but also does not lead to more serious side effects, making it an appealing alternative to traditional treatment methods.
The results were quite revealing. Our findings showed that the modified bismuth quadruple therapy group had a significantly higher eradication rate of 93.5%, compared to 69.6% in the standard treatment group. This suggests that the addition of zinc carnosine to the treatment regimen could enhance the effectiveness of indigestion relief. Importantly, the side effects reported between the two groups were similar, with only mild dizziness noted in those receiving the new therapy.
Overall, the study indicates that a shorter course of therapy that includes zinc carnosine may be a superior option for individuals suffering from indigestion related to Helicobacter pylori. This approach not only appears to work better but also does not lead to more serious side effects, making it an appealing alternative to traditional treatment methods.
References
- Ibrahim N, El Said H, Choukair A. Zinc carnosine-based modified bismuth quadruple therapy standard triple therapy for eradication: A randomized controlled study. World J Clin Cases. 2022;10:227. doi:10.12998/wjcc.v10.i1.227
